Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
28 hedge funds and large institutions have $3.26M invested in Zomedica Corp. in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 15 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
28% less funds holding
Funds holding: 39 → 28 (-11)
41% less capital invested
Capital invested by funds: $5.55M → $3.26M (-$2.3M)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$122K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$67.6K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$59.8K |
| 4 |
Goldman Sachs
New York
|
+$53.9K |
| 5 |
Morgan Stanley
New York
|
+$31.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$610K |
| 2 |
State Street
Boston,
Massachusetts
|
-$157K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$58K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$26K |
| 5 |
Bank of New York Mellon
New York
|
-$25K |
ZOM Hedge Fund Activity: Q2 2019 in Review
28 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2019, worth a combined $3.26M — down 41% from $5.55M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ZOM and 6 opened new positions — a net loss of 9 holders — while 7 trimmed existing stakes and 10 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $122K. The largest seller was BlackRock, exiting entirely with an estimated $610K sold.
- 28 institutional investors held Zomedica Corp. (ZOM) as of Q2 2019, down from 39 in Q1 2019.
- Funds reported $3.26M of Zomedica Corp. stock for Q2 2019, down 41% quarter-over-quarter.
- 6 funds opened new Zomedica Corp. positions in Q2 2019 and 15 closed out, a net change of -9 holders.
- The largest Zomedica Corp. buyer in Q2 2019 was Millennium Management, an estimated $122K added.
- The largest Zomedica Corp. seller in Q2 2019 was BlackRock, an estimated $610K sold.
Based on aggregated 13F filings for Q2 2019.